- Home
- ANIX vs INO Comparison
ANIX vs INO Comparison
Compare ANIX & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANIX | INO |
|---|---|---|
| Founded | 1982 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.0M | 118.9M |
| IPO Year | 2013 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ANIX | INO |
|---|---|---|
| Price | $2.95 | $1.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | $9.00 | $9.00 |
| AVG Volume (30 Days) | 141.7K | ★ 1.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 12.82 | ★ 35.14 |
| EPS | ★ N/A | N/A |
| Revenue | $210,000.00 | ★ $42,220,086.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $23,060.18 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 19.37 |
| 52 Week Low | $2.33 | $1.30 |
| 52 Week High | $5.46 | $2.86 |
Technical Indicators
Market Signals| Indicator | ANIX | INO |
|---|---|---|
| Relative Strength Index (RSI) | 45.34 | 56.73 |
| Support Level | $2.69 | $1.70 |
| Resistance Level | $3.00 | $2.11 |
| Average True Range (ATR) | 0.17 | 0.10 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 70.42 | 51.64 |
Price Performance
Historical ComparisonAbout ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.